BACKGROUND Recently, the entity of retinal angiomatous proliferation (RAP) as a subtype of exudative age-related macular degeneration was described, but no treatment options have been established as yet. The only two therapeutic modalities being discussed are surgical lysis of the feeding arteriole and draining venule, and the use of photodynamic therapy combined with intravitreal triamcinolone...

Aim: To investigate the intraocular pressure (IOP) response after intravitreal injections of triamcinolone acetonide as treatment of intraocular neovascular or oedematous diseases. Methods: The prospective consecutive non-comparative interventional case series study included 71 patients (75 eyes) with progressive exudative age related macular degeneration (n = 64 eyes) or diffuse diabetic macul...

To compare the efficacy of intravitreal bevacizumab and macular laser vis-a-vis intravitreal triamcinolone acetonide and macular laser in primary treatment for diabetic macular edema. Randomised, prospective, comparative two-arm, non-interventional study with five time points. 60 eyes of 30 patients with bilateral DME and no previous ocular intervention participated in the study and were random...

purpose: to report treatment with intravitreal triamcinolone acetonide (ivta) in a patient with cystoid macular edema (cme) secondary to retinitis pigmentosa (rp). case report: a 22-year-old male patient with rp presented with progressive visual loss. visual acuity was 9/10 in the right eye and 10/10 in the left eye without refractive error. examination revealed cme in the right eye. after fail...

Aim: To investigate the intraocular pressure (IOP) response after intravitreal injections of triamcinolone acetonide as treatment of intraocular neovascular or oedematous diseases. Methods: The prospective consecutive non-comparative interventional case series study included 71 patients (75 eyes) with progressive exudative age related macular degeneration (n = 64 eyes) or diffuse diabetic macul...

OBJECTIVE To evaluate the outcome of repeated intravitreal injections of triamcinolone acetonide for the treatment of exudative age-related macular degeneration. METHODS This prospective, comparative nonrandomized clinical interventional study included 13 patients with progressive exudative age-related macular degeneration with occult, or predominantly occult, subfoveal neovascularization. Al...

PURPOSE To compare the efficacy and safety of current treatments in diabetic macular edema (DME). METHODS PubMed, Embase and CENTRAL were systematically reviewed for randomized controlled trials of current treatments in DME through August 2015. Data on the mean change of best-corrected visual acuity (BCVA) and central macular thickness (CMT) were extracted, and adverse events (AEs) were colle...

Dear Editor: Miyamoto et al show that intravitreal triamcinolone reduces macular edema as early as 1 hour after injection. They suggest that the time pattern demands that nongenomic mechanisms must be involved in the therapeutic effect of triamcinolone on retinal edema. Vasogenic edema in all tissues, including the retina, may be understood in terms of Starling’s law, by which the balance of hy...